<?xml version="1.0" encoding="UTF-8"?>
<p>During the study period, a total of 2502 patients were suspected to have dengue fever, out of which 464 (18.5%) samples were found to be positive. In our study population, the highest numbers of dengue-positive cases were screened in the year 2017 (74.8%), followed by 2013 (27.7%) and 2016 (18.8%) as shown in [
 <xref rid="T1" ref-type="table">Table 1</xref>]. A majority of the cases were males 268 (57.7%) and females were 196 (42.2%). About 45% of positive cases belonged to adult age groups (18â€“44 years) followed by younger age group &lt;18 years (30%) [
 <xref rid="T2" ref-type="table">Table 2</xref>]. Fever was the most common clinical presentation which was found among all the patients, followed by headache (78.4%), myalgia (61.2%), body pain (49.3%), vomiting (40%), joint pain (31%), dry cough (19%), nausea (13.5%), abdominal pain (8%), diarrhea (5.6%), retro-orbital pain (4%), burning micturition (2.5%), and rashes (0.6%) [
 <xref rid="T3" ref-type="table">Table 3</xref>]. In this study, 90 (19.3%) patients had atypical manifestations. Hepatomegaly [32 (7%)] was the most common manifestation, followed by splenomegaly [23 (5%)], bradycardia [18 (4%)], meningitis [6 (1.2%)], hemoptysis [5 (1%)], acalculous cholecystitis [4 (0.8%)], and acute pancreatitis [2 (0.4%)] [
 <xref rid="T4" ref-type="table">Table 4</xref>]. The majority of the patients were positive for NS
 <sub>1</sub> Ag 290 (62.5%) followed by IgG 80 (17.2%), IgM 53 (11.4%), and IgM + IgG 41 (9%) as shown in [
 <xref rid="T5" ref-type="table">Table 5</xref>]. Raised HCT was found in 29 (6.2%) and leukopenia (&lt;4000/mm
 <sup>3</sup>) was found in 77 (16.5%) patients. Thrombocytopenia was observed in 179 (38.5%) cases [
 <xref rid="T6" ref-type="table">Table 6</xref>].
</p>
